VCEL250117P60000
- 4.36
- 0.000.00%
Vericel Newsroom
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $72
Investing in Vericel (NASDAQ:VCEL) Five Years Ago Would Have Delivered You a 216% Gain
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $67
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $72
Vericel (VCEL) Receives a Buy From TD Cowen
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $66
Leerink Partners Sticks to Its Buy Rating for Vericel (VCEL)
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $66
Vericel Price Target Raised to $66 From $56 at BTIG
Express News | Vericel Corp : Leerink Partners Raises Target Price to $64 From $57
Vericel Is Maintained at Buy by Canaccord Genuity
Vericel Analyst Ratings
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $60
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $61
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60
Ladenburg Thalmann Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $56
A Quick Look at Today's Ratings for Vericel(VCEL.US), With a Forecast Between $56 to $60